Search is Powered by Google
Clinical Trials / Drug Trials News

HHS OIG Report Cites Problems With FDA Oversight Of Clinical Trials

Main Category: Clinical Trials / Drug Trials
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 01 Oct 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:2 stars

2 (1 votes)

Article Opinions: 0 posts

FDA does not take adequate action to ensure the safety of millions of participants in clinical trials, according to a report from the HHS Office of Inspector General scheduled for release on Friday, the New York Times reports.

According to the report, written by HHS Inspector General Daniel Levinson, FDA -- which oversees trials conducted by companies that seek approval to market medications and medical devices -- lacks information on the number of ongoing trials, audits less than 1% of trial sites and often performs inspections of the sites after the completion of trials. FDA has 200 inspectors, some of whom audit trials part time, to inspect about 350,000 sites, the report found. In addition, the report found that FDA officials downgrade serious violations found by inspectors at trial sites 68% of the time and that the agency in many cases does not perform additional inspections to determine whether recommended corrective actions occurred.

The report recommended that FDA establish a registry of all ongoing trials, a complete registry of research ethics boards and a database of inspections of trial sites, as well as obtain more authority to regulate research assistants.

According to some research ethics experts, the problems with FDA oversight of trials cited in the report are, "in many ways, identical to criticisms leveled at other agency functions, including its oversight of imported food, foreign drug manufacturers, animal food and the safety of older medicines," as the "size and complexity of the tasks facing the agency have grown enormously as the number of inspectors for those tasks has generally declined," the Times reports (Harris, New York Times, 9/28).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
MS Damage May Be Reversed By Leukemia Drug
23 Oct 2008
Researchers in the UK found that alemtuzumab, a drug initially developed to treat leukemia, stopped the advance of multiple sclerosis (MS) in patients with early stage active relapsing-remitting multiple sclerosis (RRMS)...


Involving Your Kids in Their Nutrition
Involving Your Kids in Their Nutrition

Nutrition experts recommend getting your kids involved in their nutrition decisions, and making sure they understand why good nutrition is important.

more videos are available in our health videos section.